
Experts: Medicaid Cuts Could Prove Fatal for Thousands
Historic Coverage Loss Could Cause Over 51,000 People to Lose Their Lives Each Year, New Analysis Finds
Blog Post
Only about one million of the 14.5 million Americans with alcohol use disorder receive treatment for it in a given year. For those Americans, sustained recovery often relies on post-treatment continuing care. But continuing care is frequently upended by a wide range of barriers, including transportation needs, employment or family responsibilities, and illness or disability.
Advances in technology have made remote options to continuing care more feasible, potentially easing many of the challenges to in-person continuing care. Adding to the growing body of research examining the efficacy of remote options in the treatment of alcohol use disorder, James McKay and colleagues evaluated the effect of continuing care delivered via telephone support, a smartphone program, and a combination of both.
In the recently published study in Addiction, patients with alcohol use disorder who were receiving intensive outpatient treatment with publicly funded programs in Philadelphia were randomized into a control group or one of three intervention groups. The patients in these groups received additional remote support consisting of 12 months of either: (1) telephone monitoring and counseling, which included calls by trained staff who provided tailored cognitive behavioral therapy; (2) the ACHESS smartphone program, an app which offers access to a number of recovery tools including daily and weekly self-assessments, rapid connections to social supports, tutorials on coping with stressors, and relaxation aids with minimal monitoring by clinical staff; or (3) both telephone and smartphone support.
During the 12-month study period, patients who received only intensive outpatient care (control group) had the highest average percentage of days of heavy drinking at 10.9. The telephone monitoring and counseling group (5.41) and the smartphone program group (6.8) and the group who received both telephone and smartphone support (5.99) all had fewer heavy drinking days than the control condition, but did not differ from each other. Notably, patients who received either telephone monitoring and counseling or the telephone plus smartphone intervention were also better at avoiding alcohol altogether than the control condition. But at 18 months, six months after the continuing care ended, there was no significant difference in drinking among the four patient groups, indicating an overall erosion of treatment effects. These findings are particularly relevant as alcohol consumption increased overall in the United States during the COVID-19 pandemic. While the long-term impact of this increase in drinking is unknown, a rise in alcohol use disorder is likely, along with a concomitant need for treatment and post-treatment support. Based on the study by McKay and colleagues, providing remote continuing care improves alcohol use outcomes, with little difference between telephone counseling, smartphone app, and integrated telephone counseling plus smartphone-app interventions.
The study, Efficacy and Comparative Effectiveness of Telephone and Smartphone Remote Continuing Care Interventions for Alcohol Use Disorder: A Randomized Controlled Trial, was published in Addiction in May 2022. Authors include James McKay, David H. Gustafson, Megan Ivey, Klaren Pe-Romashko, Brenda Curtis, Tyrone Thomas, David W. Oslin, Daniel Polsky, Andrew Quanbeck, and Kevin G. Lynch.
Historic Coverage Loss Could Cause Over 51,000 People to Lose Their Lives Each Year, New Analysis Finds
Cited for “Breaking New Ground” in the Field of Hospital Operations
Men are Stepping Up at Home, but Caregiving Still Falls On Women and People of Color LDI Fellow Says
More Flexible Methadone Take-Home Policy Improved Patient Autonomy
Penn LDI Seminar Details How Administrative Barriers, Subsidy Rollbacks, and Work Requirements Will Block Life-Saving Care
His data-driven initiatives risk violating consent, spreading stigma, and reviving vaccine misinformation, LDI Fellow writes.